However, once commenced for CKD, the SGLT-2 inhibitor should be continued until kidney replacement therapy (i.e
Research suggesting individual aging trajectories must be taken into account when prescribing GLP-1 therapies
Variability in Proglucagon-Derived Peptide Sequences Previous studies had found that the proglucagon-derived peptide GLP-1 7-37 sequence displays lower levels of variability (i.e., numbers of substitutions at a site and the number of sites accepting substitutions) than glucagon, while GLP-2 was the most variable ( 1-37 , GLP-1 7-37 , GLP-2, IP-1, IP-2, and MPGF peptide sequences using predicted Gcg protein sequences from a much larger number of mammalian species than used in earlier studies
J Obes Metab Syndr 2021;30:129.ArticlePubMedPMC 19
Simultaneously, these medications suppress glucagon secretion, a hormone that raises blood glucose levels